Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

DEIDRE L ALBANESE

Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family

NPI
1750703542
CMS profile
10579983
Location
WASHINGTON, PA

General Payments · PY2024

$443.94

  • Reported across 17 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$443.94

17 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $443.94 17

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
REVANCE THERAPEUTICS, INC. $421.95 16
Galderma Laboratories, L.P. $21.99 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2024 $443.94 17

Payment records · PY2024 (17)

Sorted by paying entity, then date · as published by CMS

Program year 2024
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Galderma Laboratories, L.P. $21.99 09/19/2024 Food and Beverage Undisputed 01/23/2026 1145338433 CMS
REVANCE THERAPEUTICS, INC. $12.50 10/24/2024 Food and Beverage Undisputed 01/23/2026 1147932828 CMS
REVANCE THERAPEUTICS, INC. $49.99 10/30/2024 Food and Beverage Undisputed 01/23/2026 1147932830 CMS
REVANCE THERAPEUTICS, INC. $37.47 10/30/2024 Food and Beverage Undisputed 01/23/2026 1147932832 CMS
REVANCE THERAPEUTICS, INC. $8.48 10/30/2024 Food and Beverage Undisputed 01/23/2026 1147932834 CMS
REVANCE THERAPEUTICS, INC. $12.50 10/30/2024 Food and Beverage Undisputed 01/23/2026 1147932836 CMS
REVANCE THERAPEUTICS, INC. $12.50 11/29/2024 Food and Beverage Undisputed 01/23/2026 1147932838 CMS
REVANCE THERAPEUTICS, INC. $12.50 11/30/2024 Food and Beverage Undisputed 01/23/2026 1147932840 CMS
REVANCE THERAPEUTICS, INC. $47.89 12/05/2024 Food and Beverage Undisputed 01/23/2026 1147932842 CMS
REVANCE THERAPEUTICS, INC. $15.00 12/15/2024 Food and Beverage Undisputed 01/23/2026 1147932844 CMS
REVANCE THERAPEUTICS, INC. $121.57 12/16/2024 Food and Beverage Undisputed 01/23/2026 1147932846 CMS
REVANCE THERAPEUTICS, INC. $7.04 12/17/2024 Food and Beverage Undisputed 01/23/2026 1147932848 CMS
REVANCE THERAPEUTICS, INC. $9.73 12/18/2024 Food and Beverage Undisputed 01/23/2026 1147932850 CMS
REVANCE THERAPEUTICS, INC. $8.37 12/22/2024 Food and Beverage Undisputed 01/23/2026 1147932852 CMS
REVANCE THERAPEUTICS, INC. $35.58 12/23/2024 Food and Beverage Undisputed 01/23/2026 1147932854 CMS
REVANCE THERAPEUTICS, INC. $19.93 12/30/2024 Food and Beverage Undisputed 01/23/2026 1147932856 CMS
REVANCE THERAPEUTICS, INC. $10.90 12/31/2024 Food and Beverage Undisputed 01/23/2026 1147932858 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2024
Source files
Dataset page · Bulk file · PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.